A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.
作者： Anthony Gonçalves , Séverine Esteyries , Brynn Taylor-Smedra , Arnaud Lagarde , Mounay Ayadi
关键词:
摘要: … EGFR copy number was quantified by fluorescence in situ hybridization (FISH). KRAS exon … copy number by FISH and sequenced the extracellular domains (ECD) of EGFR, as well as …
biomedcentral.com
springer.com
doaj.org参考文章(28)
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Wu Zhang, Jan Stoehlmacher, David J. Park, Dongyun Yang, Erin Borchard, Ji Gil, Denice D. Tsao-Wei, Jim Yun, Michael Gordon, Oliver A. Press, Katrin Rhodes, Susan Groshen, Heinz-Josef Lenz, Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer. Clinical Colorectal Cancer. ,vol. 5, pp. 124- 131 ,(2005) , 10.3816/CCC.2005.N.025
F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel, T Frebourg, Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. ,vol. 96, pp. 1166- 1169 ,(2007) , 10.1038/SJ.BJC.6603685
T Sauer, M G Guren, T Noren, S Dueland, Demonstration of EGFR gene copy loss in colorectal carcinomas by fluorescence in situ hybridization (FISH): a surrogate marker for sensitivity to specific anti‐EGFR therapy? Histopathology. ,vol. 47, pp. 560- 564 ,(2005) , 10.1111/J.1365-2559.2005.02252.X
T. Moriai, M. S. Kobrin, C. Hope, L. Speck, M. Korc, A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 10217- 10221 ,(1994) , 10.1073/PNAS.91.21.10217
Thomas D. Barber, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Somatic Mutations ofEGFRin Colorectal Cancers and Glioblastomas New England Journal of Medicine. ,vol. 351, pp. 2883- 2883 ,(2004) , 10.1056/NEJM200412303512724
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
T. Moriai, M.S. Kobrin, M. Korc, Cloning of a variant epidermal growth factor receptor. Biochemical and Biophysical Research Communications. ,vol. 191, pp. 1034- 1039 ,(1993) , 10.1006/BBRC.1993.1321
Jinru Shia, David S Klimstra, Allan R Li, Jing Qin, Leonard Saltz, Julie Teruya-Feldstein, Muzaffar Akram, Ki Young Chung, Davis Yao, Philip B Paty, William Gerald, Beiyun Chen, Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Modern Pathology. ,vol. 18, pp. 1350- 1356 ,(2005) , 10.1038/MODPATHOL.3800417
Shiqing Li, Karl R. Schmitz, Philip D. Jeffrey, Jed J.W. Wiltzius, Paul Kussie, Kathryn M. Ferguson, Structural basis for inhibition of the epidermal growth factor receptor by cetuximab Cancer Cell. ,vol. 7, pp. 301- 311 ,(2005) , 10.1016/J.CCR.2005.03.003